• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Overall Survival of Patients With Pyruvate Kinase Deficiency in the UK: A Real-World Study.

作者信息

Foy Patrick, Higa Sara, Zhao Jing, Keapoletswe Karabo, Cirneanu Lorena, Venerus Alessandra, Raiteri Louise, Landfeldt Erik, Iob Eleonora, Lombard Louise, Li Junlong, Zagadailov Erin

机构信息

Division of Hematology and Oncology Medical College of Wisconsin Milwaukee Wisconsin USA.

Agios Pharmaceuticals, Inc. Cambridge Massachusetts USA.

出版信息

EJHaem. 2025 Mar 3;6(2):e70009. doi: 10.1002/jha2.70009. eCollection 2025 Apr.

DOI:10.1002/jha2.70009
PMID:40034869
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11875059/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7631/11875059/26d0bbf28b5e/JHA2-6-e70009-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7631/11875059/26d0bbf28b5e/JHA2-6-e70009-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7631/11875059/26d0bbf28b5e/JHA2-6-e70009-g001.jpg

相似文献

1
Overall Survival of Patients With Pyruvate Kinase Deficiency in the UK: A Real-World Study.英国丙酮酸激酶缺乏症患者的总生存期：一项真实世界研究。
EJHaem. 2025 Mar 3;6(2):e70009. doi: 10.1002/jha2.70009. eCollection 2025 Apr.
2
Mortality among US veterans with a physician-documented diagnosis of pyruvate kinase deficiency.
Hematology. 2024 Dec;29(1):2290746. doi: 10.1080/16078454.2023.2290746. Epub 2023 Dec 14.
3
Psychometric validation of the Pyruvate Kinase Deficiency Diary and Pyruvate Kinase Deficiency Impact Assessment in adults in the phase 3 ACTIVATE trial.在 3 期 ACTIVATE 试验中对成年人的丙酮酸激酶缺乏症日记和丙酮酸激酶缺乏症影响评估进行心理测量学验证。
J Patient Rep Outcomes. 2023 Nov 9;7(1):112. doi: 10.1186/s41687-023-00650-3.
4
Mitapivat: A Review in Pyruvate Kinase Deficiency in Adults.米他培坦：成人丙酮酸激酶缺乏症的治疗药物。
Drugs. 2023 Nov;83(17):1613-1620. doi: 10.1007/s40265-023-01961-x. Epub 2023 Nov 22.
5
The pyruvate kinase (PK) to hexokinase enzyme activity ratio and erythrocyte PK protein level in the diagnosis and phenotype of PK deficiency.丙酮酸激酶（PK）与己糖激酶酶活性比值和红细胞 PK 蛋白水平在 PK 缺乏症的诊断和表型中的应用。
Br J Haematol. 2021 Mar;192(6):1092-1096. doi: 10.1111/bjh.16724. Epub 2020 May 28.
6
Pyruvate kinase activators for treatment of pyruvate kinase deficiency.丙酮酸激酶激活剂治疗丙酮酸激酶缺乏症。
Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):97-106. doi: 10.1182/hematology.2023000466.
7
Development of the pyruvate kinase deficiency diary and pyruvate kinase deficiency impact assessment: Disease-specific assessments.丙酮酸激酶缺乏症日记和丙酮酸激酶缺乏症影响评估的制定：疾病特异性评估。
Eur J Haematol. 2020 May;104(5):427-434. doi: 10.1111/ejh.13376. Epub 2020 Feb 24.
8
Prevalence of pyruvate kinase deficiency: A systematic literature review.丙酮酸激酶缺乏症的患病率：系统文献回顾。
Eur J Haematol. 2020 Aug;105(2):173-184. doi: 10.1111/ejh.13424. Epub 2020 Jun 23.
9
Comorbidities and complications in adults with pyruvate kinase deficiency.丙酮酸激酶缺乏症成人患者的合并症和并发症
Eur J Haematol. 2021 Apr;106(4):484-492. doi: 10.1111/ejh.13572. Epub 2021 Jan 24.
10
The burden of disease in pyruvate kinase deficiency: Patients' perception of the impact on health-related quality of life.丙酮酸激酶缺乏症的疾病负担：患者对其健康相关生活质量影响的认知。
Eur J Haematol. 2018 Dec;101(6):758-765. doi: 10.1111/ejh.13128. Epub 2018 Sep 28.

本文引用的文献

1
Mortality among US veterans with a physician-documented diagnosis of pyruvate kinase deficiency.
Hematology. 2024 Dec;29(1):2290746. doi: 10.1080/16078454.2023.2290746. Epub 2023 Dec 14.
2
Health-related quality of life and fatigue in children and adults with pyruvate kinase deficiency.丙酮酸激酶缺乏症患儿及成人的健康相关生活质量和疲劳状况。
Blood Adv. 2022 Mar 22;6(6):1844-1853. doi: 10.1182/bloodadvances.2021004675.
3
Comorbidities and complications in adults with pyruvate kinase deficiency.丙酮酸激酶缺乏症成人患者的合并症和并发症
Eur J Haematol. 2021 Apr;106(4):484-492. doi: 10.1111/ejh.13572. Epub 2021 Jan 24.
4
The variable manifestations of disease in pyruvate kinase deficiency and their management.丙酮酸激酶缺乏症的疾病表现多变及其处理方法。
Haematologica. 2020 Sep 1;105(9):2229-2239. doi: 10.3324/haematol.2019.240846.
5
Prevalence of pyruvate kinase deficiency: A systematic literature review.丙酮酸激酶缺乏症的患病率：系统文献回顾。
Eur J Haematol. 2020 Aug;105(2):173-184. doi: 10.1111/ejh.13424. Epub 2020 Jun 23.
6
Addressing the diagnostic gaps in pyruvate kinase deficiency: Consensus recommendations on the diagnosis of pyruvate kinase deficiency.解决丙酮酸激酶缺乏症的诊断差距：丙酮酸激酶缺乏症诊断的共识建议。
Am J Hematol. 2019 Jan;94(1):149-161. doi: 10.1002/ajh.25325. Epub 2018 Nov 28.
7
Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study.丙酮酸激酶缺乏症的临床谱：来自丙酮酸激酶缺乏症自然史研究的数据。
Blood. 2018 May 17;131(20):2183-2192. doi: 10.1182/blood-2017-10-810796. Epub 2018 Mar 16.